Skip to main content

Don Turner

CEO, Neosinus Health & NeoPath Wellness

Don Turner has more than 28 years of experience building and managing world-class companies, with a passion for commercializing high-impact innovations on a global basis across more than 130 countries. He currently serves as the Chairman and CEO for Neosinus Health and Board Member for University of North Carolina’s Center for the Business of Health.

Previously, Don served as the SVP and Global Head of Commercialization for IBM Watson Health, SVP and Global Head of Commercialization at Merge Healthcare, Managing Director for Millennium Pharmaceuticals, Committee Chairman at Mass Biotechnology Council, and Advisory Board Member for Cisco Systems, and Board Chairman for several startup ventures.

He is an internationally recognized thought leader and public speaker, with noted expertise in areas such as advanced research and development, innovation commercialization, precision medicine, healthcare transformation, digital healthcare, drug delivery systems, and nanotechnology.

Don received the CEO Monthly Magazine’s 2021 Global CEO Award in Healthcare for Best Drug Development Platform and will be on the cover of MedTech Outlook Magazine’s 2022 Drug Delivery Special Edition as the featured cover story, where Neosinus was selected as Best-in-Class among the top-10 drug delivery companies in the word (Medtronic, Insulet Corporation, and others).

He has served as a keynote speaker at numerous international conferences on Drug Delivery, Nanomedicine, and Neuroscience. Don has also been a guest on numerous podcasts and served as a guest speaker on Healthcare Transformation and Precision Medicine at Johns Hopkins University, Duke University, Emory University, American Diabetes Association, Southeast Medical Device Association, Global Scholars Conference Circuit, eHealth Forum, BioIT Conference, American Innovators Association, and at numerous other venues.

To meet with Don, or any of our excellent mentors, please fill out this interest form.